SUPERITR
LIVE

Serial Number

98718389

Owner

Genecraft incorporated

Attorney

Sangwon Kim

Filing Date

Aug 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

SUPERITR Trademark

Serial Number: 98718389

SUPERITR is a trademark filed by Genecraft incorporated on August 27, 2024. The trademark is classified under Class 1 (Chemicals). The application is currently pending registration.

Owner Contact Info

Genecraft incorporated

CHUNGDAE-RO, SEOWON-GU, CHEONGJU-SI
CHUNGCHEONGBUK-DO 28644 , KR

Entity Type: 03

Trademark Details

Filing Date

August 27, 2024

Registration Date

June 23, 2026

Goods & Services

cell growth media for scientific purposes, namely, for cell cultures and for laboratory, scientific research, biological processing and the production of pharmaceuticals; sera samples for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; buffer solutions for scientific purposes, namely, for cell cultures and chromatography for laboratory, scientific research, biological processing and the production of pharmaceuticals; amino acids for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; proteins for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; biological samples in the nature of blood cells for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; biological raw materials in the nature of blood cells for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; reagents for scientific purposes, namely, for the collection, transportation, storage and analysis of samples and specimens for laboratory, scientific, research, or biopharmaceutical manufacturing purposes; chemical preparations for scientific purposes, namely, for the collection, transportation, storage and analysis of samples and specimens for laboratory, scientific, research, or biopharmaceutical manufacturing purposes; chemical substances for in vitro laboratory use, other than for medical or veterinary purposes; oligonucleotide for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals; plasmids for scientific purposes, namely, for laboratory, scientific research, biological processing and the production of pharmaceuticals

Filing History

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
May 28, 2026 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 19, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 11, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 11, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 11, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2026 CRFA
ASSIGNED TO LIE
Apr 21, 2026 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 15, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 22, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 22, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 22, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 19, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2025 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 8, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
May 8, 2025 GNSL
SUSPENSION LETTER WRITTEN
May 8, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 1, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2025 NWOS
NEW APPLICATION ENTERED
Aug 27, 2024 NWAP